Contact Us

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Chronic diseases often lead to catastrophic damage to vital organs. This damage is usually irreversible and leads to lifetime dependency on medicines. Under such severe conditions, transplants remain the component for restoration of healthy life.

There is increasing demand for tissue and organ transplantation, especially, especially from high income countries. Higher prevalence of diseases such as diabetes, cancer, cardiovascular diseases, renal diseases, and Alzheimer’s disease have posed a threat of irreversible tissue damage to a large population, globally. For instance, according to the Centers for Disease Control and Prevention (CDC) estimations 2019, the chronic kidney disease is more common in people of age 65 years or above and around 125,000 people in the U.S. started treatment for end-stage kidney disease (ESKD) and over 726,000 (2 in every 1,000 people) in 2018 were on dialysis or were living with a kidney transplant.  

The global tissue and organ transplantation market is estimated to be valued at US$ 13.9  Billion in 2020 and is expected to exhibit a CAGR of 9.1%  during the forecast period (2020-2027).

Figure 1. Global Tissue and Organ Transplantation Market Share (%) Analysis, By Application, 2020

Tissue and Organ Transplantation  | Coherent Market Insights

Increasing number of people suffering from organ failure is expected to drive growth of the global tissue and organ transplantation market

According to the World Health Organization (WHO) Global Observatory on Donation and Transplantation 2014, around 119,873 organs are transplanted annually worldwide. Moreover, increasing number of chronic diseases leading to organ failure and habits such as smoking and drinking further leading to organ disability are expected to fuel growth of the tissue and organ transplantation market over the forecast period. For instance, according to the Health Resources and Services Administration, till May 2017, there were around 117,829 patients waiting for organ transplants in the U.S., among which about 97,610 were waiting for kidney transplants. However, only 11,061 transplant procedures were performed from January to April 2017. Thus, increasing number of people awaiting organ and tissue transplant and increasing mortality rate due to the inadequate organ and tissue for transplantation might create opportunities in the tissue and organ transplantation market.

request-sample

Tissue and Organ Transplantation Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2020: US$ 13.9 Bn
Historical Data for: 2017 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 9.1% 2027 Value Projection: US$ 25.6 Bn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product Type: Tissue Products, Preservation Solution, Immunosuppressive Drugs.
  • By Application: Organ Transplantation, Tissue Transplantation.
  • By End User: Hospital, Transplant Centers, Others.
Companies covered:

CryoLife, Inc., Folio Biosciences, Arthrex, Abbvie, Inc., Zimmer Biomet, Medtronic PLC, Novartis AG, Stryker Corporation, BiolifeSolutions, Inc. , Teva Pharmaceuticals, and Veloxis Pharmaceutical

Growth Drivers:
  • Increasing number of people suffering from organ failure
  • Increasing prevalence of chronic diseases
Restraints & Challenges:
  • Shortage of organs for the treatment of organ failure

Tissue and Organ Transplantation Market- Restraints

The shortage of organs for the treatment of organ failure is expected to hamper the global tissue and organ transplantation market growth. There is a huge gap between demand and supply of organs for organ failure treatment. For instance, according to the U.S. Department of Health & Human Services, in 2019, there were around 43,201 patients with kidney transplant requirements in the U.S., however, only 23,401 kidney transplant procedures were performed.

Furthermore, according to the World Health Resources & Services Administration, 17 people die each day waiting for an organ transplant in the U.S.

Tissue and Organ Transplantation Market– Regional Analysis

North America accounted for the largest market share in 2019 in the tissue and organ transplantation market, owing to increasing number of organ transplant surgeries in the U.S. For instance, according to the Mayo Foundation for Medical Education and Research (MFMER), in 2017, around 8,000 liver transplants were performed in the U.S. among both adults and children. Of those, around 360 involved livers from living donors. At the same time, around 11,500 people were registered on the waiting list for a liver transplant.

Furthermore, Asia Pacific is expected to witness the fastest growth during the forecast period, owing to increasing prevalence of chronic diseases. For instance, according to the global burden of disease study 2016, the estimated prevalence of cardiovascular diseases (CVDs) in India was estimated to be 54.5 million. One in 4 deaths in India is due to CVDs including ischemic heart disease and stroke.

Figure 2. Global Tissue and Organ Transplantation Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2027

Tissue and Organ Transplantation  | Coherent Market Insights

Tissue and Organ Transplantation Market- Competitive Landscape

Key players operating in the tissue and organ transplantation market include CryoLife, Inc., Folio Biosciences, Arthrex, Abbvie, Inc., Zimmer Biomet, Medtronic PLC, Novartis AG, Stryker Corporation, BiolifeSolutions, Inc. , Teva Pharmaceuticals, and Veloxis Pharmaceutical.

Transplantation is a complex area of medicine because when organs or tissues are transplanted from one person to another, the recipient’s immune system can reject and destroy the donor organ or tissue and medication would be needed to suppress this immune response.

Organ transplantation is the surgical operation carried out for replacement of damaged organ of an individual. Donated organs are obtained from living donor, deceased donor or from an animal. Whereas in some cases, an artificial organ is used for the transplantation procedure.

Market Dynamics

The global tissue and organ transplantation market is expected to witness significant growth during the forecast period, owing to the technological advancements in transplantation procedures. For instance, in May 2016, Immucor, Inc., a global leader in transfusion and transplantation diagnostics, launched kidney Solid Organ Response Test, kSORT. It is a molecular gene expression assay that measures a kidney recipient’s immune response to predict organ rejection and graft injury.

Key features of the study:

  • This report provides in-depth analysis of the global tissue and organ transplantation market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2020-2027, considering 2019 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global tissue and organ transplantation market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include CryoLife, Inc., Folio Biosciences, Arthrex, AbbVie, Inc., Zimmer Biomet, Medtronic PLC, Novartis AG, Stryker Corporation, Biolife Solutions, Inc. , Teva Pharmaceuticals, and Veloxis Pharmaceutical
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future product launches, government initiatives, technological up gradation, market expansion, and marketing tactics
  • The global tissue and organ transplantation market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers in the tissue and organ transplantation market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Tissue and Organ Transplantation Market, By Product Type:
    • Tissue Products
    • Preservation Solution
    • Immunosuppressive Drugs
  • Global Tissue and Organ Transplantation Market, By Application:
    • Organ Transplantation
    • Tissue Transplantation
  • Global Tissue and Organ Transplantation Market, By End User:
    • Hospital
    • Transplant Centers
    • Others
  • Global Tissue and Organ Transplantation Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
      • By Product Type:
        • Tissue Products
        • Preservation Solution
        • Immunosuppressive Drugs
      • By Application
        • Organ Transplantation
        • Tissue Transplantation
      • By End User:
        • Hospital
        • Transplant Centers
        • Others
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
      • By Product Type:
        • Tissue Products
        • Preservation Solution
        • Immunosuppressive Drugs
      • By Application
        • Organ Transplantation
        • Tissue Transplantation
      • By End User:
        • Hospital
        • Transplant Centers
        • Others
    • Asia Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
      • By Product Type:
        • Tissue Products
        • Preservation Solution
        • Immunosuppressive Drugs
      • By Application
        • Organ Transplantation
        • Tissue Transplantation
      • By End User:
        • Hospital
        • Transplant Centers
        • Others
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • By Product Type:
        • Tissue Products
        • Preservation Solution
        • Immunosuppressive Drugs
      • By Application
        • Organ Transplantation
        • Tissue Transplantation
      • By End User:
        • Hospital
        • Transplant Centers
        • Others
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
      • By Product Type:
        • Tissue Products
        • Preservation Solution
        • Immunosuppressive Drugs
      • By Application
        • Organ Transplantation
        • Tissue Transplantation
      • By End User:
        • Hospital
        • Transplant Centers
        • Others
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
      • By Product Type:
        • Tissue Products
        • Preservation Solution
        • Immunosuppressive Drugs
      • By Application
        • Organ Transplantation
        • Tissue Transplantation
      • By End User:
        • Hospital
        • Transplant Centers
        • Others
  • Company Profiles
    • CryoLife, Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Folio Biosciences
    • Arthrex
    • Abbvie, Inc.
    • Zimmer Biomet
    • Medtronic PLC
    • Novartis AG
    • Stryker Corporation
    • BiolifeSolutions, Inc.
    • Teva Pharmaceuticals
    • Veloxis Pharmaceutical

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Regulatory Scenario
    • Impact Analysis
    • PEST Analysis
    • Porter’s Analysis
    • Advancements in Technological Innovations
    • Market Trends
    • Growth in Transplant Tourism
    • Key Developments
  4. Tissue and Organ Transplantation Market - Impact of Coronavirus (Covid-19) Pandemic
    • Supply side Analysis
    • Demand Side Analysis
    • Impact on Healthcare Industry
  5. Global Tissue and Organ Transplantation Market, By Product Type, 2016 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Tissue Products
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Preservation Solution
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Immunosuppressive Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  6. Global Tissue and Organ Transplantation Market, By Application, 2016 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Organ transplantation
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Tissue transplantation
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  7. Global Tissue and Organ Transplantation Market, By End User, 2016 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospital
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Transplant Centers
      • Introduction
      • Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Others
      • Introduction
      • Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  8. Global Tissue and Organ Transplantation Market, By Region, 2016 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, By Region, 2017 – 2027
      • Regional Trends
    • North America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Million)
        • North Africa
        • Central Africa
        • South Africa
    • Middle East
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • GCC
        • Israel
        • Rest of Middle East
  9. Competitive Landscape
    • Company Profiles
      • CryoLife, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Folio Biosciences
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Arthrex
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Abbvie, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Zimmer Biomet
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Medtronic PLC
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Novartis AG
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Stryker Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • BiolifeSolutions, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Teva Pharmaceuticals
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Veloxis Pharmaceutical
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
  10. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 35 market data tables and 31 figures on "Global Tissue and Organ Transplantation Market” - Forecast to 2027”

Frequently Asked Questions

The CAGR of the tissue and organ transplantation market is expected to be 9.1% during the forecast period (2020-2027).
The tissue and organ transplantation market is estimated to be valued at US$ 13.9 Billion in 2020.
The prominent players operating in the global tissue and organ transplantation market include CryoLife, Inc., Folio Biosciences, Arthrex, Abbvie, Inc., Zimmer Biomet, Medtronic PLC, Novartis AG, Stryker Corporation, BiolifeSolutions, Inc., Teva Pharmaceuticals, and Veloxis Pharmaceutical.
The tissue and organ transplantation market is expected to be valued at US$ 25.6 Billion in 2027.
North America is the major region in the tissue and organ transplantation market.
Increasing number of people suffering from organ failure and increasing prevalence of chronic diseases are expected to drive growth of the global tissue and organ transplantation market.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner